QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Patients with atopic dermatitis can be accurately identified by algorithm
Quantify’s Gustaf Ortsäter, Kirk Geale and Alexander Rieem Dun have published an observational cohort study which validates an algorithm using skin-specific diagnoses from secondary care and pharmacy-dispensed prescriptions to identify patients with atopic dermatitis.
The study shows that pediatric patients with atopic dermatitis can be accurately identified by the algorithm, but further adjustments are required to identify adult patients. This work is important for future studies that […]
Alzheimer’s disease in a Swedish context
Sweden is a pioneer country when it comes to Alzheimer’s research, and great progress has been made in recent years. Head on over to https://lnkd.in/gVNBKAJd to read an interview with Quantify partner Anders Gustavsson and Karolinska institutet professor Bengt Winblad, on their white paper on Alzheimer’s disease in a Swedish context. (all texts in Swedish).
Happy Holidays!
From the entire Quantify team to all of our clients, collaborators and friends – Happy Holidays and Happy New Year! We hope that 2022 brings happiness and success to you all. #HappyHolidays #NewYear #2022
We support Doctors Without Borders
Every year at Christmas, we at Quantify Research make a donation to an organization that is very close to our hearts – Doctors Without Borders (MSF). MSF annually runs around 450 projects in more than 70 countries around the world. Their tireless humanitarian work around the globe is an inspiration to us, and we hope it inspires you […]